Vivo Capital VIII, LLC 13D and 13G filings for Sinovac Biotech Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-11 5:35 pm Unchanged | 2025-07-11 | 13D | SINOVAC BIOTECH LTD SVA | Vivo Capital VIII, LLC | 4,541,764 6.300% | 0 (Unchanged) | Filing |
| 2025-06-13 6:26 pm Purchase | 2025-06-11 | 13D | SINOVAC BIOTECH LTD SVA | Vivo Capital VIII, LLC | 4,541,764 6.300% | 2,308 (+0.05%) | Filing |
| 2025-04-24 5:00 pm Purchase | 2025-04-23 | 13D | SINOVAC BIOTECH LTD SVA | Vivo Capital VIII, LLC | 4,539,456 6.300% | 4,539,456 (New Position) | Filing |